Impact of managed care on the treatment of atrial fibrillation

The American Journal of Cardiology
C M Pratt

Abstract

In the era of managed care, it has been necessary to develop new and innovative treatment strategies for the treatment of cardiovascular disease. This article examines our experience providing cardiovascular services to a large health maintenance organization (HMO). The focus of this article is on our development and implementation of a systematic approach to the management of atrial fibrillation (AFib), encouraging the active participation of the family practice and internal medicine physicians. With > 22 geographically diverse satellite clinics, the standardization of treatment of a common disease such as AFib is both challenging and difficult. The first objective for Baylor Cardiology was to adapt to such a system and provide an efficient and flexible schedule encouraging communication with the primary care doctor. A telephone consultation service was instituted to provide instant cardiology consultation. The HMO organizational structure allowed us to implement standardized procedures and clinical approaches. Guidelines were implemented to address all practical clinical issues in AFib such as: (1) the necessity for hospitalization; (2) baseline noninvasive studies; and (3) standardization of protime and international normali...Continue Reading

References

May 7, 1992·The New England Journal of Medicine·E L Pritchett
Nov 29, 1990·The New England Journal of Medicine·UNKNOWN Boston Area Anticoagulation Trial for Atrial Fibrillation InvestigatorsJ Philip Kistler
Nov 26, 1993·The American Journal of Cardiology·S N SinghC Colling

❮ Previous
Next ❯

Citations

Mar 18, 1999·The American Journal of Cardiology·A NabarH J Wellens
Oct 3, 2002·Dimensions of Critical Care Nursing : DCCN·Linda Josephson, Maureen McMullen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.